Log in

HEM Hemostemix Inc TSXV · Canada

Hemostemix (HEM) news

Hemostemix Inc is a public biotech or pharmaceutical company listed on TSXV under the ticker HEM, recorded under Canada. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Hemostemix news

We have not published a story on Hemostemix yet. When there is news, it will appear here.

Questions about Hemostemix

What is the ticker symbol of Hemostemix?

Hemostemix Inc trades under the ticker HEM on TSXV.

Where is Hemostemix listed?

Hemostemix Inc is listed on TSXV. Our directory also records these other listings: LS:A2QQGU; OTC:HMTXF.

Which country or territory is Hemostemix listed under?

Our directory records Hemostemix Inc under Canada.

What does Hemostemix do?

Our directory classifies Hemostemix Inc as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Hemostemix?

The ISIN recorded for Hemostemix Inc is CA4236943060.

Does aibio.space cover Hemostemix?

aibio.space lists Hemostemix Inc among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Hemostemix?

Companies in our directory listed in the same country and business area as Hemostemix: Rapid Dose Therapeutics, AbCellera Biologics, Sernova Biotherapeutics, Aurinia Pharmaceuticals, ZENITH CAPITAL CORPORATION, DiagnaMed Holdings.

Investor discussion: Hemostemix

Members talk about Hemostemix (HEM). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSXV:HEM on TradingView.

Listing details

Hemostemix Inc is a public biotech or pharmaceutical company listed on TSXV under the ticker HEM, recorded under Canada. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Hemostemix Inc
Ticker
HEM
Listing
TSXV
Country or territory
Canada
Business scope
Biotechnology
ISIN
CA4236943060
Other listed symbols
LS:A2QQGU; OTC:HMTXF
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.